News

Velcade is a leading cancer therapeutic used to treat patients with relapsed multiple myeloma. Under the terms of the agreement, Ortho Biotech will join Millennium in the first

The phase III study of NXY-059 failed to meet the study goal and did not improve stroke related disability. Additionally treatment with NXY-059 did not result in a

The companies were advised that the 30 day waiting period under the Hart-Scott-Rodino act was terminated early by the Federal Trade Commission. In the agreement, Eisai obtained exclusive

Tyzeka is a product of a commercialization agreement between Novartis and Idenix established in May 2003. Tyzeka rapidly and profoundly suppresses the hepatitis B virus in adult patients

Zostavax was approved by the FDA on May 25 for the prevention of shingles in individuals 60 years of age and older and is given by a single

Gemzar is an approved chemotherapy, marketed for use in pancreatic, ovarian, lung and breast cancer. Key objectives for the phase I portion of the study will be to

One of the significant risks associated with heart surgery is cognitive impairment. This can be identified a few days or weeks following the procedures and in many cases

The clinical trial will test the vaccine in a dose-escalation trial involving 24 healthy volunteers. The main parameters under examination will be safety, tolerability and immunogenicity. “The start

The termination of the agreement with PDI will be effective from December 1, 2006. The contract, which represents approximately $18 million to $20 million in revenue on an